ClassID:

2193

A01K2217/30 - CPC Classification

Classification description:

Genetically modified animals Animal model comprising expression system for selective cell killing, e.g. toxins, enzyme dependent prodrug therapy using ganciclovir

Recent Application in this class:
#1
20240090481
2024-03-21

TRANS-SPLICING METHODS AND COMPOSITIONS FOR GENERATION OF SINGLE SEX OFFSPRING

#2
20240090480
2024-03-21

SPLIT-INTEIN METHODS AND COMPOSITIONS FOR GENERATION OF SINGLE SEX OFFSPRING

#3
20240016132
2024-01-18

Gene Expression System

#4
20220408702
2022-12-29

DIRECTED CHANGES IN ORGANISM POPULATIONS

#5
20210345592
2021-11-11

Genetically modified sterile avians and method for the reconstitution thereof

#6
20210329894
2021-10-28

METHOD FOR PREPARING ALZHEIMER'S DISEASE (AD) ANIMAL MODEL

#7
20210137083
2021-05-13

Gene expression system

#8
20200188533
2020-06-18

DIET CONTROLLED EXPRESSION OF A NUCLEIC ACID ENCODING A PRO-APOPTOTIC PROTEIN

#9
20190031776
2019-01-31

Use of inhibitors of ADAM12 as adjuvants in tumor therapies

#10
20170188559
2017-07-06

GENE EXPRESSION SYSTEM

#11
20170112108
2017-04-27

GENETICALLY MODIFIED NON-HUMAN MAMMALS HAVING MODIFIED LIVER CELLS AND/OR TISSUE AND METHODS OF MAKING SAME

#12
20160324131
2016-11-10

Transgenic transchromosomal rodents for making human antibodies

#13
20160219844
2016-08-04

T cell receptors that are specific to a fluorescent protein, transgenic animals and methods of their making, isolated T cells, and methods of use

#14
20140380515
2014-12-25

Transgenic transchromosomal rodents for making human antibodies

#15
20140230080
2014-08-14

Method for inducing hepatocellular variation, and production method for chimeric non-human animal having humanized liver

#16
20130298269
2013-11-07

Compositions and methods relating to non-human animals modified to promote production of selected gametes

#17
20120233713
2012-09-13

METHODS AND SYSTEMS FOR INDUCIBLE ABLATION OF NEURAL CELLS

#18
20120167242
2012-06-28

Compositions and methods relating to non-human animals modified to promote production of selected gametes

#19
20120144505
2012-06-07

Targeted and regional cellular ablation in zebrafish

#20
20120079615
2012-03-29

KNOCK-IN MICE WITH INDUCIBLE LOSS OF EOSINOPHILS

#21
20120047588
2012-02-23

Methods for Conditional and Inducible Transgene Expression to Direct the Development of Embryonic, Embryonic Stem, Precursor and Induced Pluripotent Stem Cells

#22
20110262425
2011-10-27

THERAPEUTIC AGENT FOR MLL LEUKEMIA AND MOZ LEUKEMIA OF WHICH MOLECULAR TARGET IS M-CSF RECEPTOR, AND USE THEREOF

#23
20110041192
2011-02-17

Recombinant non-human mammalian model for hepatitis infection and immunopathogenesis

#24
20110003319
2011-01-06

Transgenic trasnchromosomal rodents for making human antibodies

#25
20100229254
2010-09-09

METHOD FOR TARGETED CELL ABLATION

#26
20100223679
2010-09-02

Targeted and regional cellular ablation in zebrafish

#27
20100115640
2010-05-06

Methods for Conditional and Inducible Transgene Espression to Direct the Development of Embryonic, Embryonic Stem, Precursor and Induced Pluripotent Stem Cells

#28
20100075414
2010-03-25

GROWTH OF FOREIGN CELLS AFTER CONDITIONAL AND SELECTIVE DESTRUCTION OF FETAL HOST CELLS

#29
20100010202
2010-01-14

Human antibodies derived from immunized xenomice

#30
20090293139
2009-11-26

DOUBLE-INDUCIBLE GENE ACTIVATION SYSTEM AND ITS APPLICATIONS

#31
20090271884
2009-10-29

ES Cell-Derived Mice From Diploid Host Embryo Injection

#32
20090193533
2009-07-30

Conditional-stop dimerizable caspase transgenic animals

#33
20070134212
2007-06-14

Growth of foreign cells in fetal animals facilitated by conditional and selective destruction of native host cells

#34
20070031434
2007-02-08

Uses for Eph receptor antagonists and agonists

#35
20060147429
2006-07-06

FACILITATED CELLULAR RECONSTITUTION OF ORGANS AND TISSUES

#36
20060037093
2006-02-16

Transgenic transchromosomal rodents for making human antibodies

#37
20060026698
2006-02-02

Transgenic transchromosomal rodents for making human antibodies

#38
20050155097
2005-07-14

Eosinophil-deficient transgenic animals

#39
20050138677
2005-06-23

Transgenic animal model for the treatment of skin tumors

#40
20050054055
2005-03-10

Human antibodies derived from immunized xenomice